Search filters

List of works by Pablo Tebas

A Pilot Study Evaluating Time to CD4 T-cell Count <350 cells/mm3 After Treatment Interruption Following Antiretroviral Therapy ± Interleukin 2: Results of ACTG A5102

article

A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults

scientific article published on 06 October 2016

A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I).

scientific article

A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus

scientific article published on 29 October 2020

A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298).

scientific article published in July 2002

A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy

scientific article

A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults

scientific article (publication date: 2011)

Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.

scientific article published in July 2011

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy

scientific article

Aging and HIV infection: a comparison between older HIV-infected persons and the general population

scientific article published on March 2010

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.

scientific article published in November 2007

Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection

scientific article published in April 2005

Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells

scientific article

Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals

scientific article

Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV

scientific article published on 20 December 2012

Association Between Porphyria Cutanea Tarda and Human Immunodeficiency Virus Infection

Association between porphyria cutanea tarda and human immunodeficiency virus infection

scientific article published in August 1992

Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy

scientific article

Bone disease and HIV infection

scientific article

Bone disease in HIV infection: a practical review and recommendations for HIV care providers

scientific article

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o

scientific article

Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results

scientific article published on 29 January 2016

Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study

scientific article published on 23 September 2016

CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.

scientific article

Cardiovascular risks of antiretroviral therapies

scientific article published on January 2007

Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study

scientific article

Cure of acute hepatitis C in HIV co-infection?

scientific article published in March 2004

Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy.

scientific article published on 27 July 2006

Current use of statins reduces risk of HIV rebound on suppressive HAART

scientific article

Cyclosporin A Provides No Sustained Immunologic Benefit to Persons with Chronic HIV‐1 Infection Starting Suppressive Antiretroviral Therapy: Results of a Randomized, Controlled Trial of the AIDS Clinical Trials Group A5138

article

DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations

scientific article published on 18 June 2007

Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19

scientific article published in 2021

Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy

scientific article

Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV‐1 Disease

article

Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication

scientific article published in July 2000

Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis

scientific article

Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption

scientific article

Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies

scientific article published on 28 August 2002

Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death

scientific article published on 05 February 2013

Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients

scientific article published on 23 October 2015

Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial: A5005s, a Substudy of AIDS Clinical Trials Group Study 384

article

Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial

scientific article published on 26 February 2016

Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.

scientific article published in November 2004

Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients

scientific article

Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression

scientific article

Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials ⬇️

scientific article published on April 24, 2012

Emerging bone problems in patients infected with human immunodeficiency virus

scientific article published in April 2003

Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function

scientific article

European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142

scientific article

Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection

scientific article published in June 2004

Explaining, Predicting, and Treating HIV-Associated CD4 Cell Loss

scientific article published in The Journal of the American Medical Association

Fat redistribution and bone abnormalities in HIV-infected patients

scientific article

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

scientific article (publication date: 6 March 2014)

Genetic analysis implicates resistin in HIV lipodystrophy

scientific article published on August 2008

Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection

scientific article published on 9 December 2003

Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks

scientific article

HIV and Cardiometabolic Abnormalities: New Perspectives and Treatment Update

article

HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells

scientific article

HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D.

scientific article published on March 2003

Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy

scientific article published in March 2008

Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients

scientific article published in December 2013

Hepatitis C virus treatment: The beginning of a new era

Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction

scientific article

High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART

scientific article

Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism

scientific article published on 17 September 2008

Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease

scientific article published in January 2009

IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation

scientific article published on March 2017

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

scientific article published on 15 May 2017

Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions

scientific article published on 22 November 2011

Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen

scientific article published on 9 April 2013

In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot study

scientific article

Increased fracture risk with HIV infection--a growing concern

scientific article

Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373.

scientific article

Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options

scientific article published on September 2008

Interventions for body habitus changes associated with HIV infection and its treatment

scientific article published on May 2007

Is it time to rethink the expanded-access programs for HIV infection?

scientific article published on 24 August 2007

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.

scientific article published on 21 July 2015

Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials

scientific article published on 11 April 2014

Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants Randomized to Nelfinavir or Efavirenz or Both Plus Dual Nucleosides

article

Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.

scientific article published on 29 January 2003

Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation

scientific article published on 13 August 2013

Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team

scientific article published in October 1998

Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus

scientific article published in September 2003

Massively parallel pyrosequencing in HIV research

scientific article published on July 2008

Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease

scientific article

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

scientific article

Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks

scientific article

Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals

scientific article

Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial

scientific article

Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant

scientific article published in January 2014

NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects

scientific article published on 28 June 2019

Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro

scientific article published on 12 January 2007

Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy

scientific article

Non-tropical pyomyositis caused by Salmonella enterica enterica in an immunocompetent patient

scientific article

Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons

scientific article

Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care

scientific article

Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents

scientific article

Patient monitoring and follow-up in lentiviral clinical trials

scientific article published in February 2013

Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration

scientific article

Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s

scientific article

Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110.

scientific article published on 19 March 2009

Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200

scientific article

Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients

article

Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips".

scientific article

Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals

scientific article published in September 2010

Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients

scientific article published on March 2007

Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults

scientific article published in May 2007

Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen

Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511).

scientific article published on October 2001

Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection

scientific article

Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient

scientific article published in February 1995

Real-Time Nucleic Acid Sequence-Based Amplification Assay to Quantify Changes in Mitochondrial DNA Concentrations in Cell Cultures and Blood Cells from HIV-Infected Patients Receiving Antiviral Therapy

article

Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults

scientific article published on May 2015

Reply to Rojo and Ramos and to Vignolo et al

scientific article published in 2006

Response to ‘Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy’ by Drs Weil and Lenhard

article

Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic

scientific article

Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection

scientific article

Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells

scientific article

Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res

scientific article published on 5 June 2014

Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants

scientific article published on January 2014

Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women

scientific article

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection

scientific article

Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients

scientific article published on 25 March 2015

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).

scientific article published on June 2007

Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals

scientific article

Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.

scientific article

The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1.

scientific article published on 02 March 2016

The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling

article

The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health

scientific article

The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection

scientific article

The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana

scientific article published on October 2008

The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.

scientific article published in March 2007

Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy.

scientific article published in March 2001

Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers

scientific article published on 04 June 2013

Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis.

scientific article published on 26 April 2017

Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model

scientific article published in October 1998

Virologic responses to a ritonavir-saquinavir-containing regimen in patients who had previously failed nelfinavir

article

Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals

scientific article

Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial

scientific article

Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection

scientific article

Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density

scientific article published on August 2013

Paulina is supported by:

About Paulina

Help